The Food and Drug Administration last week approved the anti-clotting drug Eliquis (apixaban), an oral tablet used to reduce the risk of stroke and dangerous blood clots in patients with atrial fibrillation that is not caused by a heart valve problem. Eliquis is manufactured by Bristol-Myers Squibb, and marketed by BMS and Pfizer.
Watson Pharmaceuticals on Friday confirmed that Actavis, which was acquired by Watson in October, has filed an abbreviated new drug applications with the Food and Drug Administration seeking approval to market bortezomib, a generic version of Millennium Pharmaceuticals' Velcade.
ProPhase Labs recently announced that its Cold-Eeze Cold Remedy will be sponsoring a New Jersey television personality to help raise money for Camp Sunshine, a retreat in Casco, Maine for kids with life threatening illnesses and their families.
Walgreens on Thursday announced $100,000 in additional donations to Hurricane Sandy relief efforts. The company, which includes Duane Reade in New York and New Jersey, is making two $50,000 contributions.
The consumer products division of British drug maker GlaxoSmithKline wants its voice heard at a Food and Drug Administration hearing scheduled for next year on a section in a 2009 law to regulate tobacco products that deals with smoking-cessation products, the company said Monday.
GlaxoSmithKline Consumer Healthcare and TV personality Samantha Harris have teamed up to announce the launch of "Let's Fight Holiday Fat" — a new, free online guide that provides weight maintenance support for Americans trying to squeeze in healthy eating and exercise this season.
NeoStrata, the creator of the original lunchtime glycolic acid peel, has unveiled its new Exuviance Age Reverse HydraFirm, which targets all visible signs of aging and rehydrates the skin at deep levels so skin looks and feels younger.